USA |NASDAQ |USD
Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
---|---|---|---|---|
Jul 27, 2022 | Jun 2022 | $-0.41 | - | $-0.10 |
Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
---|---|---|---|---|
Jul 27, 2022 | Jun 2022 | $3.40M | - | $2.21M |
Ekso Bionics's next earnings date is Wednesday, Jul 27, 2022 for the fiscal quarter ending Jun 2022.
Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
---|---|---|---|---|
Jun 2022 | 1 | $-0.41 | $-0.41 | $-0.41 |
Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
---|---|---|---|---|
Dec 2022 | 1 | $-1.61 | $-1.61 | $-1.61 |
Dec 2023 | 1 | $-1.12 | $-1.12 | $-1.12 |
Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
---|---|---|---|---|
Jun 2022 | 0 / 0 | $-0.26 | $-0.26 | $-0.26 |
Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
---|---|---|---|---|
Dec 2022 | 0 / 0 | $-1.01 | $-1.01 | $-1.01 |
Dec 2023 | 0 / 0 | $-0.79 | $-0.79 | $-0.79 |
Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
---|---|---|---|---|
Jun 2022 | 1 | $3.40M | $3.40M | $3.40M |
Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
---|---|---|---|---|
Dec 2022 | 1 | $14.17M | $14.17M | $14.17M |
Dec 2023 | 1 | $22.28M | $22.28M | $22.28M |
Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
---|---|---|---|---|
Apr 27, 2022 | Mar 2022 | $-0.41 | - | - |
Feb 24, 2022 | Dec 2021 | $-0.25 | $-0.23 | 8.00% |
Nov 2, 2021 | Sep 2021 | $-0.25 | $-0.15 | 40.00% |
Jul 29, 2021 | Jun 2021 | $-0.25 | $-0.10 | 60.00% |
Apr 29, 2021 | Mar 2021 | $-0.24 | $-0.34 | -41.67% |
Feb 25, 2021 | Dec 2020 | $-0.30 | $-0.48 | -60.00% |
Oct 29, 2020 | Sep 2020 | $-0.39 | $0.30 | 176.92% |
Jul 30, 2020 | Jun 2020 | $-0.56 | $-1.88 | -238.74% |
Apr 30, 2020 | Mar 2020 | $-0.61 | $-0.44 | 27.87% |
Feb 27, 2020 | Dec 2019 | $-0.65 | $-0.60 | 7.69% |
Oct 30, 2019 | Sep 2019 | $-1.05 | $0.04 | 103.86% |
Aug 1, 2019 | Jun 2019 | $-1.20 | $-0.60 | 50.00% |
May 1, 2019 | Mar 2019 | $-1.20 | $-1.50 | -25.00% |
Feb 28, 2019 | Dec 2018 | $-1.20 | $-1.05 | 12.50% |
Nov 7, 2018 | Sep 2018 | $-1.35 | $-1.65 | -22.22% |
Aug 7, 2018 | Jun 2018 | $-1.65 | $-1.95 | -18.18% |
May 7, 2018 | Mar 2018 | $-1.65 | $-1.95 | -18.18% |
Mar 13, 2018 | Dec 2017 | $-1.50 | $-2.25 | -50.00% |
Nov 8, 2017 | Sep 2017 | $-1.95 | $-2.70 | -38.46% |
Aug 7, 2017 | Jun 2017 | $-4.50 | $-4.78 | -6.27% |
May 9, 2017 | Mar 2017 | $-6.00 | $-5.70 | 5.00% |
Mar 7, 2017 | Dec 2016 | $-6.00 | $-4.35 | 27.50% |
Nov 9, 2016 | Sep 2016 | $-5.15 | $-9.00 | -74.76% |
Jul 28, 2016 | Jun 2016 | $-4.58 | $-9.15 | -100.00% |
May 10, 2016 | Mar 2016 | $-4.55 | $-6.60 | -45.05% |
Mar 14, 2016 | Dec 2015 | $-5.25 | $-9.45 | -80.00% |
Nov 5, 2015 | Sep 2015 | $-0.30 | $-0.35 | -16.67% |
Aug 11, 2015 | Jun 2015 | $-0.24 | $-0.42 | -75.00% |
May 7, 2015 | Mar 2015 | $-0.28 | $-0.28 | - |
Mar 17, 2015 | Dec 2014 | $-0.21 | $-0.42 | -100.00% |
Nov 10, 2014 | Sep 2014 | - | $-4.72 | - |
Aug 8, 2014 | Jun 2014 | - | $-4.80 | - |
Mar 31, 2014 | Mar 2014 | - | $-128.00 | - |
Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
---|---|---|---|---|
Feb 24, 2022 | Dec 2021 | $0.00 | $-0.82 | - |
Feb 25, 2021 | Dec 2020 | $-1.74 | $-2.50 | - |
Feb 27, 2020 | Dec 2019 | $-0.20 | $-2.66 | - |
Feb 28, 2019 | Dec 2018 | $-0.45 | $-6.60 | - |
Mar 13, 2018 | Dec 2017 | $-0.81 | $-15.43 | - |
Mar 7, 2017 | Dec 2016 | - | $-29.10 | - |
Mar 14, 2016 | Dec 2015 | - | $-10.50 | - |
Mar 17, 2015 | Dec 2014 | - | $-137.94 | - |
Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
---|---|---|---|---|
Apr 27, 2022 | Mar 2022 | $3.20M | - | - |
Feb 24, 2022 | Dec 2021 | $2.80M | $4.08M | 1.46% |
Nov 2, 2021 | Sep 2021 | $2.58M | $3.05M | 1.18% |
Jul 29, 2021 | Jun 2021 | $2.10M | $2.21M | 1.05% |
Apr 29, 2021 | Mar 2021 | $3.00M | $1.91M | 0.64% |
Feb 25, 2021 | Dec 2020 | $2.25M | $2.25M | 1.00% |
Oct 29, 2020 | Sep 2020 | $2.90M | $2.90M | 1.00% |
Jul 30, 2020 | Jun 2020 | $1.62M | $2.26M | 1.40% |
Apr 30, 2020 | Mar 2020 | $1.41M | $1.47M | 1.04% |
Feb 27, 2020 | Dec 2019 | $3.65M | $3.72M | 1.02% |
Oct 30, 2019 | Sep 2019 | $3.15M | $3.32M | 1.05% |
Aug 1, 2019 | Jun 2019 | $3.26M | $3.26M | 1.00% |
May 1, 2019 | Mar 2019 | $3.90M | $3.62M | 0.93% |
Feb 28, 2019 | Dec 2018 | $3.86M | $3.30M | 0.85% |
Nov 7, 2018 | Sep 2018 | $2.86M | $2.55M | 0.89% |
Aug 7, 2018 | Jun 2018 | $3.03M | $2.97M | 0.98% |
May 7, 2018 | Mar 2018 | $2.98M | $2.52M | 0.84% |
Mar 13, 2018 | Dec 2017 | $3.00M | $2.45M | 0.82% |
Nov 8, 2017 | Sep 2017 | - | $1.60M | - |
Aug 7, 2017 | Jun 2017 | - | $1.87M | - |
May 9, 2017 | Mar 2017 | - | $1.44M | - |
Mar 7, 2017 | Dec 2016 | - | $2.59M | - |
Nov 9, 2016 | Sep 2016 | - | $1.60M | - |
Jul 28, 2016 | Jun 2016 | - | $1.55M | - |
May 10, 2016 | Mar 2016 | - | $8.49M | - |
Mar 14, 2016 | Dec 2015 | - | $1.94M | - |
Nov 5, 2015 | Sep 2015 | - | $2.92M | - |
Aug 11, 2015 | Jun 2015 | - | $2.11M | - |
May 7, 2015 | Mar 2015 | - | $1.69M | - |
Mar 17, 2015 | Dec 2014 | - | $1.48M | - |
Nov 10, 2014 | Sep 2014 | - | $1.59M | - |
Aug 8, 2014 | Jun 2014 | - | $1.20M | - |
Mar 31, 2014 | Mar 2014 | - | $1.06M | - |
Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
---|---|---|---|---|
Feb 24, 2022 | Dec 2021 | $9.93M | $11.25M | 13.25% |
Feb 25, 2021 | Dec 2020 | $8.88M | $8.88M | 0.00% |
Feb 27, 2020 | Dec 2019 | $13.87M | $13.92M | 0.34% |
Feb 28, 2019 | Dec 2018 | $11.90M | $11.33M | -4.77% |
Mar 13, 2018 | Dec 2017 | $8.00M | $7.35M | -8.09% |
Mar 7, 2017 | Dec 2016 | - | $14.22M | - |
Mar 14, 2016 | Dec 2015 | - | $8.66M | - |
Mar 17, 2015 | Dec 2014 | - | $5.33M | - |
EKSO's next earnings date is Wednesday, Jul 27, 2022 for the fiscal quarter ending Jun 30, 2022.
According to analysts, the average EPS estimation for Ekso Bionics's next quarterly earnings is $-0.41, with a low EPS estimation of $-0.41, and a high estimation of $-0.41.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.26, the last 2 month trend is $-0.26, and the 3 month trend is $-0.26.
Based on analysts, the average revenue estimation is $3.40M, with a low revenue estimation of $3.40M, and a high estimation of $3.40M.
Ekso Bionics's previous earnings date was Apr 27, 2022 for its fiscal quarter ended Mar 31, 2022.
Ekso Bionics's previous annual earnings date was Feb 24, 2022 for its fiscal year ended Dec 31, 2021.
EKSO's earnings per share (EPS) was $-0.82, missing the consensus analysts forecast of $0.00 by % , and higher than the previous year's EPS (Dec 2020) by -67.20%.
Revenues were $11.25M, better than the forecast of $9.93M by 13.25%, and up by 26.62% from previous year's revenue.
The company reported a net income of $-9.76M.
Ekso Bionics reported a free cash flow of $-11.21M for its fiscal year, compared to $-8.76M a year ago.
The company ended the fiscal year with $2.22M in total debt, a decrease of -42.38% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.